AUTHOR=Mo Yuanyuan , Lei Zhiying , Chen Mei , Deng Hongyan , Liang Rong , Yu Miaoyu , Huang Huiqiao 

TITLE=Effects of self-help mindfulness-based cognitive therapy on mindfulness, symptom change, and suicidal ideation in patients with depression: a randomized controlled study

JOURNAL=Frontiers in Psychology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1287891

DOI=10.3389/fpsyg.2023.1287891

ISSN=1664-1078

ABSTRACT=<sec id="sec1"><title>Objective</title><p>This study aimed to evaluate the effects of self-help mindfulness-based cognitive therapy (MBCT-SH) on mindfulness, symptom change, and suicidal ideation in patients with depression.</p></sec><sec id="sec2"><title>Methods</title><p>For this randomized controlled study, 97 patients were randomly assigned to either the MBCT-SH (<italic>n</italic> = 48) or control (<italic>n</italic> = 49) group. The Five Facet Mindfulness Questionnaire (FFMQ), Hamilton Depression Rating Scale (HAMD-24), and Suicide Attitude Questionnaire (SAQ) were used to assess mindfulness, depression symptoms, and suicidal ideation, respectively, at baseline (T0), intervention week 4 (T1), intervention week 8 (T2), and 3-month follow-up (T3). The groups were also compared on treatment costs and readmission rates at a 6-month follow-up.</p></sec><sec id="sec3"><title>Results</title><p>In the MBCT-SH group, 46 of 48 participants (96%) completed the eight-week program. At T0, there were no statistically significant between-group differences in demographics, clinical characteristics, FFMQ, HAMD-24, or SAQ. Nor were there statistically significant differences on the HAMD-24 or SAQ between the MBCT-SH and control groups at T1 (<italic>p</italic> = 0.18 and <italic>p</italic> = 0.59, respectively), while mindfulness was significantly higher in the MBCT-SH group (<italic>t</italic> = 2.383, <italic>p</italic> = 0.019). At T2, there were significant between-group differences on the FFMQ, HAMD-24, and SAQ, all of which remained significant at T3. At the 6-month follow-up, <italic>per capita</italic> treatment costs were 5,298 RMB lower in the MBCT-SH group compared with the control group, while their readmission rates (6.1% and 4.2%, respectively) did not differ significantly.</p></sec><sec id="sec4"><title>Conclusion</title><p>These findings support the feasibility and effectiveness of MBCT-SH among patients with depression.</p></sec><sec><title>Clinical trial registration</title><p><ext-link xlink:href="http://www.chictr.org.cn" ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn</ext-link>, ChiCTR2300077850.</p></sec>